Literature DB >> 14646561

Apoptosis and mammary gland involution: reviewing the process.

P A Furth1, U Bar-Peled, M Li.   

Abstract

Apoptosis is a process of programmed cell death. Mammary gland involution is a tissue remodelling process. Mammary epithelial cell apoptosis is an integral component of tissue remodelling but it is only one element. Equally important are the factors which degrade basement membrane and extracellular matrix. Both operations are required for completion of mammary gland involution. The primary apoptotic process occurs first and is temporally distinct from the second stage of involution typified by lobular-alveolar collapse. Local factors related to milk accumulation trigger the first stage, but loss of systemic hormonal stimulation governs the second stage. Changes in the expression patterns of cell cycle control genes and bcl-2 family member genes are found in the first stage. Proteinase gene activation dominates the second stage. These findings support a two stage model of mammary gland involution. Both mammary epithelial cell apoptosis and mammary gland remodelling advance through a process which includes both loss of survival factors and gain of death factors. This review focuses on signalling pathways and genetic controls which are activated and repressed during mammary gland involution.

Entities:  

Year:  1997        PMID: 14646561     DOI: 10.1023/a:1026454207398

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  14 in total

Review 1.  The fur seal-a model lactation phenotype to explore molecular factors involved in the initiation of apoptosis at involution.

Authors:  Julie A Sharp; Christophe Lefevre; Amelia J Brennan; Kevin R Nicholas
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

Review 2.  The beginning of the end: death signaling in early involution.

Authors:  Fiona O Baxter; Kevin Neoh; Maxine C Tevendale
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

3.  Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8.

Authors:  Rikinari Hanayama; Shigekazu Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

Review 4.  Apoptosis and traumatic brain injury.

Authors:  Jill Wong; Ng Wai Hoe; Feng Zhiwei; Ivan Ng
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

5.  Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity.

Authors:  L O'Leary; A M van der Sloot; C R Reis; S Deegan; A E Ryan; S P S Dhami; L S Murillo; R H Cool; P Correa de Sampaio; K Thompson; G Murphy; W J Quax; L Serrano; A Samali; E Szegezdi
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

6.  Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland function.

Authors:  Yi Sun; Kelli Boyd; Wu Xu; Jing Ma; Carl W Jackson; Amina Fu; Jonathan M Shillingford; Gertraud W Robinson; Lothar Hennighausen; Johann K Hitzler; Zhigui Ma; Stephan W Morris
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

7.  Three-dimensional cultures of mouse mammary epithelial cells.

Authors:  Rana Mroue; Mina J Bissell
Journal:  Methods Mol Biol       Date:  2013

8.  Analysis of inhibitor of apoptosis protein family expression during mammary gland development.

Authors:  Thomas W Owens; Fiona M Foster; Jolanta Tanianis-Hughes; Julia Y Cheung; Lisa Brackenbury; Charles H Streuli
Journal:  BMC Dev Biol       Date:  2010-06-28       Impact factor: 1.978

9.  Inflammatory responses in epithelia: endotoxin-induced IL-6 secretion and iNOS/NO production are differentially regulated in mouse mammary epithelial cells.

Authors:  Samar W Maalouf; Rabih S Talhouk; Floyd L Schanbacher
Journal:  J Inflamm (Lond)       Date:  2010-11-30       Impact factor: 4.981

10.  Hormonal induction and roles of Disabled-2 in lactation and involution.

Authors:  Wensi Tao; Robert Moore; Elizabeth R Smith; Xiang-Xi Xu
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.